ACTIVE

COMMUNICATION CONSULTING MARKETING PHARMA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result41,6 k €-13,7 %over 1 year
Gross margin71,2 k €-8,4 %over 1 year
Equity262,3 k €+18,9 %over 1 year

Identity

Source · BCE/KBO

COMMUNICATION CONSULTING MARKETING PHARMA is a Private limited company incorporated in 2001. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Wemmel.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0475.754.613
Incorporation
02/10/2001
Legal form
Private limited company
Registered office
Val Brabançon 15
1780 Wemmel · FlandreSee on map
Contributed capital
12 400,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin71,2 k €77,7 k €87,6 k €136,2 k €22,8 k €
EBITDA70,7 k €77,3 k €86,4 k €135,9 k €22,4 k €
Operating result56,9 k €64,1 k €73,7 k €129 k €19,1 k €
Net result41,6 k €48,2 k €50,3 k €82,8 k €15 k €
Balance sheet
Equity262,3 k €220,7 k €172,5 k €122,2 k €39,3 k €
Total assets266,8 k €235,2 k €228,1 k €172,8 k €73,5 k €
Cash89,3 k €51,1 k €107,7 k €80,8 k €1,3 k €
Debts4,5 k €14,5 k €55,6 k €50,6 k €34,1 k €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

Johan Smitz

Director · since 01 janvier 2014

Active

Ended mandates

Johan Smitz

Manager · since 01 janvier 2014

Ended
ANDRE PIETTE

Mandate

Ended
André PIETTE

Manager

Ended
Carole PIETTE

Manager

Ended

Other companies at this address

Val Brabançon 15 1780 Wemmel
CompanyCBE no.
Smitz-Otsuki● Active
0847.376.756

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/06/202609/07/202527/06/202410/07/202319/06/202229/07/2021
General meeting01/06/202602/06/202503/06/202405/06/202307/06/202207/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202501/06/202630/06/2026DutchPDF
Micro model31/12/202402/06/202509/07/2025DutchPDF
Micro model31/12/202303/06/202427/06/2024DutchPDF
Micro model31/12/202205/06/202310/07/2023DutchPDF
Micro model31/12/202107/06/202219/06/2022DutchPDF
Micro model31/12/202007/06/202129/07/2021DutchPDF
Micro model31/12/201902/06/202021/08/2020FrenchPDF
Abridged model31/12/201803/06/201931/12/2019DutchPDF
Abridged model31/12/201704/06/201814/12/2018DutchPDF
Abridged model31/12/201605/06/201731/08/2017DutchPDF
Abridged model31/12/201506/06/201627/08/2016DutchPDF
Abridged model31/12/201401/06/201531/08/2015DutchPDF
Abridged model31/12/201302/06/201420/08/2014DutchPDF
Abridged model31/12/201203/06/201322/08/2013DutchPDF
Abridged model31/12/201104/06/201231/08/2012DutchPDF
Abridged model31/12/201006/06/201130/08/2011DutchPDF
Abridged model31/12/200907/06/201031/08/2010DutchPDF
Abridged model31/12/200802/06/200930/09/2009FrenchPDF
Abridged model31/12/200706/03/200830/09/2008FrenchPDF
Abridged model31/12/200604/06/200729/08/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

Johan Smitz

Director · since 01 janvier 2014

Active

Ended mandates

Johan Smitz

Manager · since 01 janvier 2014

Ended
ANDRE PIETTE

Mandate

Ended
André PIETTE

Manager

Ended
Carole PIETTE

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates04/07/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
    PDF
  • Mandates30/12/2014
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates03/07/2012
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office09/10/2006
    SIEGE SOCIAL
    PDF
  • Registered office03/10/2005
    SIEGE SOCIAL
    PDF
  • Registered office02/07/2003
    SIEGE SOCIAL
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202541,6 k €↓
  2. 2024
    Annual accounts 202448,2 k €↓
  3. 2023
    Annual accounts 202350,3 k €↓
  4. 2022
    Annual accounts 202282,8 k €↑
  5. 2021
    Annual accounts 202115 k €↓
  6. 2021
    Name changeCCM PHARMA
  7. 2020
    Annual accounts 202015,1 k €↑
  8. 2019
    Annual accounts 20191,2 k €↑
  9. 2018
    Annual accounts 2018-1,9 k €↑
  10. 2017
    Annual accounts 2017-10,6 k €↓
  11. 2016
    Annual accounts 2016-4,4 k €↓
  12. 2015
    Annual accounts 2015502 €↓
  13. 2014
    Annual accounts 201418,3 k €↓
  14. 2013
    Annual accounts 201319,3 k €↓
  15. 2012
    Annual accounts 201225,3 k €↑
  16. 2011
    Annual accounts 20117,2 k €↓
  17. 2010
    Annual accounts 201012,8 k €↑
  18. 2009
    Annual accounts 2009-34,3 k €↑
  19. 2008
    Annual accounts 2008-65,9 k €↓
  20. 2007
    Annual accounts 200713,1 k €↓
  21. 2006
    Annual accounts 200621,6 k €
  22. 2006
    Name changeC.C.M. PHARMA
  23. 02/10/2001
    IncorporationPrivate limited company